Research Paper Volume 16, Issue 10 pp 9188—9203
Comprehensive analysis to identify PUS7 as a prognostic biomarker from pan-cancer analysis to osteosarcoma validation
Figure 8. PUS7 as a promising biomarker in osteosarcoma. (A) Kaplan–Meier analysis of the association between PUS7 expression and OS in GSE21257. (B) Comparison of PUS7 expression between non-metastasis and metastasis samples in osteosarcoma. (C) Comparison of PUS7 expression between tumor and normal samples in osteosarcoma. (D) The expression value of PUS7 in osteosarcoma tissue and adjacent normal specimens determined by IHC analysis. (E) The GSEA analysis between PUS7-high and-low groups in the Target-OS cohort.